Envoy Medical, Inc.COCHNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+8.1%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+8.1%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
1.3x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 68.63% |
| Q3 2025 | 8.65% |
| Q2 2025 | -9.57% |
| Q1 2025 | 11.21% |
| Q4 2024 | -10.37% |
| Q3 2024 | 6.41% |
| Q2 2024 | 9.79% |
| Q1 2024 | -22.75% |
| Q4 2023 | 65.14% |
| Q3 2023 | -14.07% |
| Q2 2023 | 11.73% |
| Q1 2023 | 33.54% |
| Q4 2022 | 54.33% |
| Q3 2022 | -31.30% |
| Q2 2022 | 30.11% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |